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Abstract
The most poisonous fish species found along the Brazilian coast is the spotted scorpionfish Scorpaena plumieri.
Though hardly ever life-threatening to humans, envenomation by S. plumieri can be quite hazardous, provoking
extreme pain and imposing significant socioeconomic costs, as the victims may require days to weeks to recover
from their injuries. In this review we will walk the reader through the biological features that distinguish this species
as well as the current epidemiological knowledge related to the envenomation and its consequences. But above all,
we will discuss the challenges involved in the biochemical characterization of the S. plumieri venom and its
compounds, focusing then on the successful isolation and pharmacological analysis of some of the bioactive
molecules responsible for the effects observed upon envenomation as well as on experimental models. Despite the
achievement of considerable progress, much remains to be done, particularly in relation to the non-proteinaceous
components of the venom. Therefore, further studies are necessary in order to provide a more complete picture of
the venom’s chemical composition and physiological effects. Given that fish venoms remain considerably less
studied when compared to terrestrial venoms, the exploration of their full potential opens a myriad of possibilities
for the development of new drug leads and tools for elucidating the complex physiological processes.
Keywords: Scorpionfish, Scorpaena plumieri venom, Inflammatory response, Proteolytic activity, Cardiovascular
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Background
The immense pharmacological potential contained in
the venoms of several species throughout the globe has
been profoundly remarked upon and — in relation to
terrestrial animals — considerably well explored. On the
other hand, marine and aquatic animals remain relatively
underrepresented in the literature [1–3]. A search in the
UniProtKB databank reveals a large number of entries
for scorpion, spider and snake protein toxins, while data
on marine and aquatic animals — particularly fish — re-
main rather scarce (Fig. 1). This discrepancy can be
somewhat explained by the fact that fish do not seem to
pose as large a threat from an epidemiological point of
view [1]. Moreover, the extreme lability of the toxic
components combined with the challenges involved in
extracting, isolating and storing the venom makes their
study and exploration a task that only the most ten-
acious researchers can perform [1, 4, 5]. Nonetheless,
fish comprise more than half of all venomous vertebrates
[6, 7], so much so that a phylogenetic analysis conducted
by Smith and Wheeler in 2006 [6] suggests that up to
1,200 fishes in 12 clades should be assumed venomous.
Thus, an effort towards a deeper understanding of fish
venoms contributes not only to the discovery of new
drug leads but also to a more efficient exploration of our
biodiversity.
The Brazilian coast is home to a large variety of ven-
omous fish species, the most poisonous being the spot-
ted scorpionfish Scorpaena plumieri [8–11]. It is
noteworthy that the Scorpaeniformes (families Scorpae-
nidae and Synanceiidae) are the most venomous marine
fishes in the world [11, 12].
S. plumieri Bloch, 1789, commonly known in Brazil as
mangangá, niquim-de-pedra or mamangava [11], can be
found along the Brazilian southeastern coast, as well as
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off Florida, in the Gulf of Mexico, the Caribbean, the
Bahamas and Bermudas. It usually dwells in shallow wa-
ters and reefs, remaining motionless and disguised
among rocks and plants [13]. This camouflaging capabil-
ity is paramount in order to ambush prey and to mislead
predators (Fig. 2a). Like other scorpionfishes, the repre-
sentatives of this species are fairly large (up to 50 cm),
with 12 dorsal, 2 pelvic and 3 anal short and thick fin
spines (Fig. 2b) covered with mucous-rich integumentary
sheath [14]. The identification of the specimens is made
through the observation of white spots or blotches on a
black background on the inner portion of the pectoral
fins [15] (Fig. 2c).
The venom gland in scorpionfishes is not a well-
defined structure, but consists of a group of secretory
cells lying within the spines anterolateral grooves, with-
out an excretory duct [11, 16]. Therefore, the venom ap-
paratus in this species comprises the spines plus the
integumentary sheath associated with them. Envenom-
ation occurs through mechanical pressure on the spines,
which tears the integumentary sheath to allow the re-
lease of the venom along with the mucus present in the
skin [17, 18]. This quite primitive venomous apparatus,
common among poisonous fishes, has evolved mostly
for defensive purposes, which is consistent with its in-
voluntary delivery mechanism [1, 2].
Humans can become victims of S. plumieri when fisher-
men, divers and bathers accidentally tread on or handle
the fish and have their skin perforated by the spines [11].
Fig. 1 Fish venoms in the literature. Comparison between the
number of entries (%) obtained through a search for sequences of
bioactive proteins from spiders, scorpions, snakes and fish in the





Fig. 2 The spotted scorpionfish Scorpaena plumieri. a Picture of a
specimen of S. plumieri highlighting its camouflage capability. b
Erected dorsal spines covered in mucous skin form — along with
the pelvic and anal fin spines — the venom apparatus of S. plumieri.
c White spots against a black background on the inner part of the
pectoral fins, a characteristic feature of this species
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The clinical manifestations of accidents include local and
systemic effects. The first symptom is always excruciating
pain, followed by edema, erythema, occasional skin necro-
sis, adenopathy, nausea, vomiting, agitation, malaise,
sweating, diarrhea, tachycardia and arrhythmias, culminat-
ing, in some cases, in severe hypotension [11]. The treat-
ment is symptomatic and usually consists of soaking the
affected limb in hot water (45–50 °C) at least until the
pain is relieved, though why such heat is effective remains
under discussion [11].
Envenomation by S. plumieri, though hardly ever life-
threatening to humans, imposes considerable socioeco-
nomic costs, given that fishermen — the group most
prone to accidents — may require days to weeks to re-
cover from their injuries [11]. And even if accidents in-
volving S. plumieri are — at least according to the
official reports made to the Notifiable Diseases Informa-
tion System (SINAN) — somewhat rare when compared
to other venomous aquatic species found in Brazil, the
potential severity of the injuries caused by these stings
justifies the need for a thorough investigation of these
cases [19].
The Laboratory of Protein Chemistry of the Federal
University of Espírito Santo (UFES), Brazil, which has
been studying the venom of S. plumieri for over a dec-
ade, is responsible for the great majority of the literature
on this topic. Considerable progress has been made in
relation to the biochemical and pharmacological prop-
erties of the crude venom extract [20–23] and a few
bioactive molecules have been isolated and analysed
[20, 24–28]. In this review, we will focus on the dis-
cussion of the chemical and physio-pharmacological
properties of S. plumieri venom along with those of
the bioactive molecules isolated so far.
Extraction and chemical composition of S.
plumieri venom
Given that the venom gland in S. plumieri is not a
well-defined structure, the collection of the venom in
an uncontaminated form is technically difficult. Hence, S.
plumieri venom studies have been conducted using the
extract from its venomous apparatus. This venomous ex-
tract (referred to as SpV) has been obtained according to
the batch method [4] adapted by Carrijo et al. [20], in
which an average-sized fish (15–20 cm) yields ≈ 10–16 mg
of total protein.
SpV is mucous-rich, which presents a considerable
challenge to its study. Nevertheless, the major hindrance
to elucidating the nature of the venom has been the in-
stability of its active components, which could be par-
tially due to the presence of endogenous proteolytic
enzymes [20, 24].
The protein complexity of SpV is evident from a num-
ber of different components found when the extract was
subjected to two-dimensional SDS-PAGE. This analysis
revealed about two hundred protein spots (6 to
120 kDa) with a predominance of anionic proteins [29].
A similar molecular weight range has been described for
the protein components of other fish venoms [30–32].
In addition to the protein constituents, some other
active compounds, such as biogenic amines have been
described in fish venoms [33–37]. However, these
components — which also present important implica-
tions for venom activity — have yet to be explored in
S. plumieri venomous extract.
Biological activities of S. plumieri venom extract
(Spv)
Studies conducted on SpV have shown the enormous di-
versity and complexity of its biological activities. SpV
was found to perform lethal, hemolytic, cardiovascular,
inflammatory, integrin-binding-inhibitory and proteo-
lytic activities [20, 22–24, 27, 29]. This spectrum of
activities — observed in experimental animals — resem-
bles those of other fish venoms previously described [1, 2].
The first study focusing on biological properties of SpV
was reported by Carrijo et al. [20]. Intravenous injection of
SpV in mice induced loss of muscular coordination, paraly-
sis, urination, hypersalivation, convulsions and respiratory
failure, followed by death. The LD50 was estimated to be
0.28 mg/kg, a value comparable to those reported for
venoms of other scorpaeniform fish [4, 38, 39]. The venom
also displays dose-dependent hemolytic activity on rabbit
erythrocytes [20]. Furthermore, as SpV lacks phospholipase
A2 activity—much like other fish venoms— the hemolysis
can be explained by pore formation activity [25].
As previously mentioned, the first and most notable
effect of the envenomation is clinically characterized by
intense edema, erythema and excruciating pain, which
are generally associated with an inflammatory response
[11]. Experiments conducted using the mice paw test
have shown that the injection of SpV into the footpad
induces intense edema that is time- and dose-dependent
[29]. In contrast, a pronounced nociceptive response
reaches a plateau at low doses (≥15 μg/paw) [29]. This
inflammatory response is characterized by a release of
pivotal pro-inflammatory mediators (TNF, IL-6 and
MCP-1) that may be associated with histopathological
changes observed in paw tissue, distinguished by cellular
infiltration of mainly neutrophils followed by mono-
nuclear cells after 12 h [23]. SpV-induced edema was
found to be significantly reduced by previous administra-
tion of a serine-protease inhibitor (aprotinin) or a bradyki-
nin B2 receptor antagonist (icatibant), while pretreatment
with a non-selective COX inhibitor (diclofenac sodium)
and a H1 receptor antagonist (promethazine) had less
effect, suggesting that the kallikrein-kinin system (KKS)
plays a major role in the edema formation [23].
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In addition to the local inflammatory response, a sys-
temic reaction is triggered after SpV injection in the
footpad or peritoneal cavity of mice, leading to endothe-
lial barrier dysfunction, microvascular hyperpermeability
and sustained inflammatory response, culminating in al-
veolar edema and neutrophilic inflammation. Alveolar
macrophages (AM) and neutrophils act as a source of
matrix metalloproteinases that together play a key role
in the cascade of events leading to lung injury. These
findings also confirm a central role for macrophage and
neutrophils in the pathogenesis of venom-induced lung
injury and also the importance of AMs in the resolution
of this SpV-triggered process [21].
These inflammatory responses may be due to the ac-
tivity of proteases, hyaluronidases and integrin-inhibiting
factors that could affect the extracellular matrix (ECM).
And indeed, enzymatic activities are prominently de-
scribed in the literature on fish — and terrestrial —
venoms [40–43]. These enzymes initiate reactions that
can contribute to local and systemic effects by acting as
“spreading factors”, either increasing tissue permeability
and facilitating the spread of other constituents of the
venom or causing direct tissue damage to the prey [44].
Furthermore, these enzymes are also involved in the
post-translational processing of the many toxins in the
venom [45].
SpV was shown to hydrolyse casein and gelatin [20].
These proteolytic activities were also reported in the
venoms of the fish Potamotrygon falkneri and Thalasso-
phyne maculosa, respectively [31, 32]. Akin to most fish
venoms, SpV is devoid of any phospholipase activity, al-
beit phospholipase C activity has been detected in the
Scatophagus argus venom [46].
Due to their pivotal role, integrins — which are recep-
tors of the ECM — are targets for several naturally oc-
curring toxins. There are several literature reports of
these molecules in snake venoms, including desintegrins
[47] and C-type lectins [48–50]. On the other hand, only
recently have these molecules been reported in fish
venoms. A cell-free binding assay showed that SpV
inhibited the binding of integrins α1β1, α2β1, α3β1 and
α7β1 to their respective ligands: collagen IV, collagen I,
laminin-332 and laminin-111 [27].
Among all the effects caused by fish venoms, cardio-
vascular activity has been the main subject of research in
the field [1, 2]. Clinical reports have shown that the
symptoms of S. plumieri envenomation include respira-
tory distress and tachycardia [11]. Similarly, it was ob-
served in animal models that SpV increases mean arterial
pressure (MAP) in a dose-dependent manner. However,
biphasic responses — characterized by an initial increase
followed by a pronounced fall of the MAP — are achieved
using higher doses (338 μg/kg), leading to the death of the
animal after a few minutes [22]. This phenomenon was
also observed in other fish venoms, such as P. volitans, S.
horrida and S. guttata. The high-pressure phase has been
associated with adrenoceptors while the hypotensive
phase seems to involve muscarinic receptors and/or nitric
oxide synthesis [51, 52].
In isolated hearts, SpV produces dose-dependent and
transient positive ventricular chronotropic, inotropic and
lusitropic effects. These responses are attenuated by a
non-selective β-adrenergic antagonist, evidencing that
the venom compounds could act — at least in part —
directly through the presence of some adrenergic agonist
in the venom and/or indirectly via the release of en-
dogenous stores of norepinephrine from the sympathetic
varicosities in the heart [22].
Besides the activity on the cardiac muscle, SpV also
produces vascular effects. SpV induces a dose-dependent
increase in perfusion pressure (CPP) on the coronary
bed, and a biphasic effect on intact and pre-contracted
rat aortic rings — characterized by an initial and transi-
ent relaxing phase followed by a sustained contractile
phase [22, 24]. It is noteworthy that variations in vascu-
lar responses induced by the same fish venom have been
observed in studies applying different experimental
models [1].
The unravelling of the precise action mechanism
behind all the biological activities attributed to venoms
depends on the isolation of the substances responsible
for each one of these activities.
An initial fractionation procedure applying gel filtration
chromatography yielded five fractions from SpV [20]. This
approach succeeded in separating the cardiovascular activ-
ity from the integrin inhibitory activity, though not from
the hemolytic or inflammatory activities. In addition, this
procedure also revealed a hemagglutinating fraction
(Fig. 3). While the proteolytic and lectin-related biological
activities were shown to be highly stable, a great deal of in-
stability was shown by the hemolytic, cardiovascular and
inflammatory activities [20, 24].
Finally, despite all the difficulties surrounding the puri-
fication of active proteins from fish venoms our group
has isolated four proteins from SpV. In the following
section we will discuss the biochemical, physiological
and pharmacological features of these proteins.
Bioactive proteins isolated from Spv
Scorpaena plumieri gelatinolytic protease (Sp-GP)
The first toxin isolated from SpV was Sp-GP, a 72 kDa
protease with gelatinolytic activity. In fact, to the best of
our knwoledge, it was the first active protein isolated
from a scorpionfish [20]. Homogeneity was reached
through three purification steps: gel filtration (Fig. 3),
ion exchange, and reverse-phase chromatography. The
ineffectiveness of efforts at N-terminal sequencing sug-
gests that the enzyme is N-terminally blocked. The
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optimal pH value for its activity was found to be within
the range of 7–8 [20]. Although many fish venoms were
found to perform proteolytic activity, the only other iso-
lated fish venom proteases comprise a group of five
toxins termed natterins (5.9–41.4 kDa) found in the
venom of the toadfish Thalassophryne nattereri. These
proteases cleave human kininogen and degrade type I
and type IV collagen in vitro. The latter leads to direct
induction of necrosis, stimulating an inflammatory re-
sponse, which, in turn, correlates with the edema-
inducing effects of the toxin [53, 54].
Lectins
Extracts from vegetable or animal sources — venoms,
for instance — have the ability to induce the agglutin-
ation of hemocytes and to disrupt cell-ECM interactions
[48, 55]. These abilities are related to the activity of mol-
ecules with carbohydrate-binding properties: the lectins.
Two lectins — (i) plumieribetin, a lectin homologous
to monocot mannose-binding B-type lectin and (ii) a
group of five isolectins (Sp-CL 1–5) homologous to fish
C-type lectins — were purified from S. plumieri venom
[27, 28].
Plumieribetin was purified with a high degree of
homogeneity by gel filtration chromatography — from
both SpV (Fig. 3) and skin mucus — as a 14 kDa band
in SDS-PAGE. Analytical gel filtration on a calibrated
size exclusion column provided several peaks, most of
which contained this same protein in different oligo-
meric states (mainly as a tetramer). Cross-linkage studies
confirmed the oligomeric nature of this integrin-
inhibiting factor. Plumieribetin is characterized by an
abundance of anti-parallel beta strands, just as the afore-
mentioned B-type lectins. The primary structure of plu-
mieribetin is highly similar to those of homologous
proteins isolated from other fishes, namely Platycephalus
indicus (71.5%), the green puffer fish Tetraodon nigrovir-
idis (63.7%) and the Japanese pufferfish T. rubripes
(56.8%) [27].
Plumieribetin binds to α1β1 integrin irrespective of N-
glycosilation — indicating direct protein-protein inter-
action — supressing α1β1 integrin binding to basement
membrane collagen IV. It could not fully detach hepato-
carcinoma HepG2 cells or primary arterial smooth
muscle cells from collagen IV fragment CB3. It did,
however, attenuate cell-collagen contacts and cell
spreading, changing the actin cytoskeleton after blocking
the compensating α2β1 integrin as well [27].
In addition to the hemagglutinating fraction (FV)
(Fig. 3), five main absorbance peaks were detected by re-
verse phase high performance liquid chromatography
(RP-HPLC) (RP1, 2, 3, 4 and 5). Mass spectrometry ana-
lysis of these fractions on matrix-assisted laser desorp-
tion/ionization — time of flight (MALDI-TOF) revealed
a high degree of homogeneity with m/z signals and mo-
lecular masses of 16.981, 16.982, 16.975, 16.841 and
16.842 kDa. The amino acid sequence of RP4 revealed
homology (24–32% of identity) with various fish C-type
lectins. Finally, the presence of the glycan moiety
galactose-β(1→ 4)-N-acetylglucosamine was also re-
vealed in the FV structure [28].
The similar chemical characteristics exhibited by RP
fractions (elution in RP-HPLC and MALDI-TOF) — to-
gether with the similarities found among amino acid se-
quences — strongly suggest that RP1-5 are C-type lectin
isoforms (isolectins) [28].
Scorpaena plumieri cytolytictoxin (SP-Ctx)
Considerable evidence suggests that the cardiovascular,
inflammatory and cytolytic effects attributed to Scorpae-
nidae fish venoms are due to the action of a single labile
“lethal protein factor” [1, 5, 56].
A cytolysin denominated Sp-CTx — a glycoprotein
with two subunits (of ≈ 65 kDa each) — was purified
from the venom of S. plumieri [24]. Next, an improved
purification approach was established, which reduced
the time and the number of chromatography steps
needed to obtain the pure toxin [25]. Due to the lability
of Sp-CTx, such a time reduction is crucial to the suc-
cess of its isolation and functional characterization.
Orbitrap-MS analyses revealed thirty-seven Sp-CTx in-
ternal amino acid sequences after proteolytic fragmenta-
tion with trypsin. Through the protein database NCBInr,
29 tryptic peptide fragments were found to have identity
Fig. 3 Elution profile of the gel filtration fractionation of the
Scorpaena plumieri extract (SpV). A sample of SpV (approximately
83 mg of protein) was applied on a Sephacryl S-200 HR column
(2.0 cm × 120 cm) previously equilibrated and eluted with 0.01 M
phosphate buffer at pH 7.6 with 0.4 M NaCl at 4 °C. Flow rate,
5.25 mL/h, fractions of 1.75 mL. Figure adapted from [27]
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with other oligomeric cytolysins (SNTX, neoVTX,
Pvtoxin or/and Patoxin, Fig. 4) from fishes belonging to
the families Scorpaenidae and Synanceiidae [25]. The
evolutionary implications of this similarity reinforces the
idea of a close relationship between scorpionfish, lionfish
and stonefish, already suggested based on phylogeny
studies [6].
Like other fish cytolysins, Sp-CTx has shown
hemolytic activity in rabbit erythrocytes attenuated by
osmotic protectants (polyethylene glycol polymers) and
molecules larger than 6 nm in diameter. This strongly
suggested that Sp-CTx might be a pore-forming protein,
since it lacks phospholipase A2 activity [25]. Further-
more, previous reports have shown that the hemolytic
effect induced by SNTX was fully prevented by osmotic
protectants of adequate size while uncharged molecules
of smaller size failed to avert cell lysis [57]. More re-
cently, the pore formation mechanism was directly visu-
alized through transmission electron microscopy of
SNTX [58].
Despite its hemolytic effect, the focus of Sp-CTx re-
search has been on its cardiovascular activities. In vivo
and in vitro (isolated hearts) studies revealed that Sp-
CTx reproduces the effects induced by SpV. In isolated
papillary muscle, Sp-CTx produces a positive inotropic
effect attenuated by propranolol and the catecholamine
releasing agent tyramine, while increasing L-type Ca2+
current density in isolated ventricular cardiomyocytes.
These results show that Sp-CTx induces cardiovascular
disorders through an increase of sarcolemmal calcium
influx, partially due to the release of endogenous nor-
adrenaline [26]. In addition, Sp-CTx reproduced the
SpV-induced effect on aortic rings, although the relax-
ation phase is less marked in this case. This relaxant ef-
fect is abolished after endothelial denudation, suggesting
that the release of endothelium-derived relaxing factors
is involved in this response [24].
Besides the cytolytic and cardiovascular effects dis-
played by cytolysins isolated from fish venoms, other
pharmacological effects such as edematogenic and noci-
ceptive activities have been reported [1]. As to Sp-CTx,
a thorough investigation of its role in the inflammatory
effect induced by SpV remains to be done.
A summary of the bioactive proteins isolated from
SpV is presented below (Table 1), along with their chem-
ical and functional features.
Molecular genetics of S. plumieri venom
The difficulties surrounding the study of fish venoms
also affect their characterization at the molecular level.
To date few reports have been published regarding the
analysis of fish venoms from a genetic point of view
[59–62]. Transcriptomic approaches performed on the
venom glands of the stingray Neotrygon kuhlii [60] and
the toadfish Thalassophryne nattereri [59] revealed a
considerable number of proteins that are related to the
pharmacological activity of these venoms — e.g. galec-
tins [60] and C-type lectins [59] — as well as some that
Fig. 4 Identity percentage (coverage id) between fish toxins (blue boxes). The number of Sp-CTx-predicted tryptic peptides (pep “matches”)
shared between corresponding subunits is represented along with the respective percentage values. The “pep” values depicted beside each blue
box stand for the number of Sp-CTx-predicted peptide fragments that are shared with each appointed subunit
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are novel to fish venoms. A preliminary analysis of
expressed sequence tags (EST) obtained through a
cDNA library from S. plumieri venom revealed that
about 30% of the sequences had no similarities with pre-
viously described ones, suggesting the presence of un-
known genes of potential relevance in the venom gland.
In addition, the screening of the library with antibodies
against a lectin fraction from S. plumieri venom has
shown that lectin-like genes account for 12% of all tran-
scripts, a finding confirmed by extensive in silico analysis
[61]. These constitute the very first steps towards the
unraveling of the molecular diversity contained in fish
venoms.
Neutralization of S. plumieri toxic activities
Although there is no antivenom available for the enve-
noming by S. plumieri, the commercial antivenom raised
against the venom of the stonefish Synanceia trachynis
(SFAV) — a horseFab’2 preparation made by CSL in
Melbourne, Australia [63] — evoked a cross-reactive im-
mune response to SpV.
SFAV neutralizes all known clinical effects of serious
S. trachynis envenomation [64], and is also efficient in
neutralising the inflammatory and cardiovascular re-
sponses as as well as the hemolytic activity induced by S.
plumieri in mice [29], suggesting that the compounds
responsible for these effects share similar biochemical
and antigenic properties to those found in stonefish
venom. This antivenom also neutralises some of the
toxic effects of other stonefish (S. verrucosa), lionfish
(Pterois volitans, P. lunulata, P. antennata and Dendro-
chirus zebra) and soldierfish (Gymnapistes marmoratus)
[51, 65, 66].
This is in accordance with the hypothesis that venom-
ous fishes belonging to different genera or inhabiting
different regions may share venom compounds with
similar antigenic properties [1].
Conclusions
In conclusion, despite all the progress made recently,
many questions remain to be answered, not only with
respect to the physio-pharmacological effects and the
precise action mechanism of some of the components
already described, but also as to the considerable num-
ber of molecules still unexplored in the venom of S. plu-
mieri. The study and exploration of the full potential
contained in fish venoms can contribute to a better un-
derstanding of complex physiological processes — such
as the very pain induced by the envenomation — and to
the discovery of new drugs, not to mention the develop-
ment of more effective ways to treat the injuries caused
by these animals.
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Table 1 Toxins purified from SpV to date
Molecule Function Toxin Name Chemical Aspects Functional Characteristics Source





(subunits ≈ 65 kDa)
Hemolytic activity — cell membrane pore formation
Cardiovascular biphasic response in vivo — initial systolic
and diastolic pressure increase followed by decrease
Positive inotropic effect on cardiac muscle
Increase of Ca2+ current on isolated cardiomyocytes
Vasoconstriction — coronary bed




B-type lectin Plumeribetin Homotetramer
(monomer — 13.157 kDa)
N-terminally blocked
High content of anti-parallel strands
Integrin inhibitory activity
Attenuation of cell-collagen contacts and cell spreading
[27]











Recognizes the sugar motif
(Gal-β(1→ 4)GlcNAc)
[28]
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